SCHEMBL26315316

SCHEMBL26315316

Cc1cc(Nc2ccc3c(c2)CN(c2cccc(Nc4ccccc4P)c2)C3=O)ccn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UGCG Q16739 1/20 0.36
CYP11B2 P19099 3/20 0.36
CYP11B1 P15538 2/20 0.36
MAPK14 Q16539 4/20 0.35
MKNK1 Q9BUB5 1/20 0.34
MKNK2 Q9HBH9 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
PKM P14618 1/20 0.34
KDM4E B2RXH2 1/20 0.34
JAK2 O60674 3/20 0.33
GRM2 Q14416 1/20 0.33
GRM1 Q13255 1/20 0.33
AXL P30530 1/20 0.33
MYLK Q15746 1/20 0.33
MAP3K5 Q99683 1/20 0.33
MAPK13 O15264 1/20 0.32
MAPK12 P53778 1/20 0.32
MAPK11 Q15759 1/20 0.32
PIK3CG P48736 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25185237 0.90 CYP11B2 (0.42) UGCGCYP11B2CYP11B1MKNK1NPC1
SCHEMBL25820854 0.89 NPC1 (0.41) UGCGCYP11B2CYP11B1MAPK14NPC1
SCHEMBL24003825 0.89 MAPK14 (0.41) UGCGCYP11B2CYP11B1MAPK14MKNK1
SCHEMBL24003824 0.86 CYP11B2 (0.42) UGCGCYP11B2CYP11B1MKNK1MKNK2
SCHEMBL24003961 0.86 CYP11B2 (0.39) UGCGCYP11B2CYP11B1MKNK1NPC1
SCHEMBL24010141 0.86 NPC1 (0.43) UGCGCYP11B2CYP11B1MKNK1NPC1
SCHEMBL24003895 0.86 CYP11B2 (0.41) UGCGCYP11B2CYP11B1MKNK1MKNK2
SCHEMBL26328138 0.85 CYP11B1 (0.35) UGCGCYP11B2CYP11B1MAPK14MKNK1
SCHEMBL25820869 0.85 CYP11B2 (0.37) UGCGCYP11B2CYP11B1MAPK14MKNK1
SCHEMBL24003831 0.85 TDO2 (0.39) UGCGCYP11B2CYP11B1MAPK14NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR UGCG 1404/4885CYP11B2 860/4885CYP11B1 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.